Several studies (4–6) have shown that tumor vascular normalization induced by vascular endothelial growth factor (VEGF) signaling inhibitors, such as bevacizumab and Endostar (recombinant human endostatin), significantly improves the outcomes of chemotherapy and radiotherapy. The gene discussed is COL18A1; the disease is neoplasm.